E-LIB Suche - Ergebnisse für: Keijzer, Sofie

1

Longitudinal rheumatoid factor autoantibody responses after..:

Keijzer, Sofie ; Oskam, Nienke ; Ooijevaar-de Heer, Pleuni...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Doxycycline induces mitochondrial dysfunction in aortic smo..:

Yap, Carmen ; Wanga, Shaynah ; Wüst, Rob C.I....
Vascular Pharmacology. 154 (2024) - p. 107279 , 2024

Link: https://doi.org/10.1016/..

3

Patient-perspective and feasibility of home finger-prick te..:

Besten, Yaëlle R ; Boekel, Laura ; Steenhuis, Maurice...
RMD Open. 10 (2024) 2 - p. e003933 , 2024

Link: https://doi.org/10.1136/..

4

Suppressed IgG4 class switching in dupilumab‐ and TNF inhib..:

Valk, Anika M. ; Keijser, Jim B. D. ; van Dam, Koos P. J....
Allergy. , 2024

Link: https://doi.org/10.1111/..

5

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afuc..:

Van Coillie, Julie ; Pongracz, Tamas ; Rahmöller, Johann...
eBioMedicine. 87 (2023) - p. 104408 , 2023

Link: https://doi.org/10.1016/..

6

Comparative analysis of spike-specific IgG Fc glycoprofiles..:

Van Coillie, Julie ; Pongracz, Tamas ; Šuštić, Tonći...
iScience. 26 (2023) 9 - p. 107619 , 2023

Link: https://doi.org/10.1016/..

7

Antibody development and disease severity of COVID-19 in no..:

Boekel, Laura ; Hooijberg, Femke ; Vogelzang, Erik H...
RMD Open. 8 (2022) 1 - p. e002035 , 2022

Link: https://doi.org/10.1136/..

8

Comparative analysis of spike-specific IgG Fc glycoprofiles..:

Van Coillie, Julie ; Pongracz, Tamas ; Šuštić, Tonći...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475480/. , 2023

Link: http://www.ncbi.nlm.nih...

9

Persistence of seroconversion at 6 months following primary..:

Wieske, Luuk ; Stalman, Eileen W ; van Dam, P J Koos...
https://research.rug.nl/en/publications/2645b3bc-4c39-4f9a-87da-1fc0bccd69d1. , 2023

Link: https://hdl.handle.net/1..

10

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P. J ; Volkers, Adriaan G ; Wieske, Luuk...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189216/. , 2023

Link: http://www.ncbi.nlm.nih...

11

Primary SARS-CoV-2 infection in patients with immune-mediat..:

van Dam, Koos P J ; Volkers, Adriaan G ; Wieske, Luuk...
https://research.rug.nl/en/publications/02f1078a-9d22-4978-894d-da2bdf428b09. , 2023

Link: https://hdl.handle.net/1..

12

Disease activity in patients with immune-mediated inflammat..:

van Dam, Koos P.J ; Wieske, Luuk ; Stalman, Eileen W...
https://research.rug.nl/en/publications/5ec1e85a-ec6c-4b98-89d2-4641ea56a756. , 2023

Link: https://hdl.handle.net/1..

13

Antibody development and disease severity of COVID-19 in no..:

Boekel, Laura ; Hooijberg, Femke ; Vogelzang, Erik H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983412/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Breakthrough infections with the SARS-CoV-2 omicron (B.1.1...:

Stalman, Eileen W ; Wieske, Luuk ; van Dam, Koos P. J...
https://research.rug.nl/en/publications/078874c1-c88e-44f9-a4da-2846bebfb376. , 2022

Link: https://hdl.handle.net/1..

15

Humoral responses after second and third SARS-CoV-2 vaccina..:

Wieske, Luuk ; van Dam, Koos P J ; Steenhuis, Maurice...
https://research.rug.nl/en/publications/2983b1d1-ec9c-4881-918f-987a2fd27816. , 2022

Link: https://hdl.handle.net/1..